Testosterone replacement therapy: Dilemmas and challenges in China and Asia.
作者信息
An Qi, Gu Yi-Qun
机构信息
Graduate School, Peking Union Medical College, Beijing 100730, China.
National Health and Family Planning Key Laboratory of Male Reproductive Health, National Research Institute for Family Planning, Beijing 100081, China.
出版信息
Asian J Androl. 2018 Mar-Apr;20(2):149-151. doi: 10.4103/aja.aja_16_17.
Abstract
摘要
相似文献
1
Testosterone replacement therapy: Dilemmas and challenges in China and Asia.睾酮替代疗法：中国及亚洲地区的困境与挑战
Asian J Androl. 2018 Mar-Apr;20(2):149-151. doi: 10.4103/aja.aja_16_17.
2
[Hormone replacement therapy in men: practical aspects].男性激素替代疗法：实际应用
Urologiia. 2011 Jul-Aug(4):68, 70-3.
3
Late-onset male hypogonadism and testosterone replacement therapy in primary care.基层医疗中的迟发性男性性腺功能减退与睾酮替代疗法
J Fam Pract. 2010 Jul;59(7 Suppl):S1-8.
4
Androgen replacement therapy in aging men.老年男性的雄激素替代疗法。
Nurse Pract. 2004 Oct;29(10):58-64. doi: 10.1097/00006205-200410000-00008.
5
Why is understanding the relationship of testosterone to cardiovascular risk so important?为什么了解睾酮与心血管风险之间的关系如此重要？
Asian J Androl. 2018 Mar-Apr;20(2):107-108. doi: 10.4103/aja.aja_71_17.
6
Testosterone deficiency and treatment in older men: definition, treatment, pitfalls.老年男性睾酮缺乏与治疗：定义、治疗及陷阱
Asian J Androl. 2010 Sep;12(5):623-5. doi: 10.1038/aja.2010.96. Epub 2010 Aug 23.
7
Testosterone replacement in men.男性睾酮替代疗法
Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):364-70. doi: 10.1097/MED.0b013e328305081a.
8
Testosterone treatment in the aging male: myth or reality?男性衰老中的睾酮治疗：是神话还是现实？
Swiss Med Wkly. 2012 Mar 19;142:w13539. doi: 10.4414/smw.2012.13539. eCollection 2012.
9
Managing endocrine dysfunction following blast injury to the male external genitalia.男性外生殖器爆炸伤后内分泌功能障碍的管理
J R Army Med Corps. 2013 Mar;159 Suppl 1:i45-8. doi: 10.1136/jramc-2013-000022.
10
Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.HIV/AIDS 男性性腺功能减退症的最佳诊断方法和阈值：两种经皮睾酮替代治疗凝胶的比较。
Postgrad Med. 2013 Mar;125(2):30-9. doi: 10.3810/pgm.2013.03.2639.
引用本文的文献
1
An Individualized Approach to Managing Testosterone Therapy in the Primary Care Setting.基层医疗环境中睾酮治疗的个体化管理方法
Int J Gen Med. 2022 Oct 7;15:7719-7733. doi: 10.2147/IJGM.S364189. eCollection 2022.
2
Prevalence of late-onset hypogonadism among middle-aged and elderly males in China: results from a national survey.中国中老年男性迟发性性腺功能减退症的患病率：一项全国性调查的结果。
Asian J Androl. 2021 Mar-Apr;23(2):170-177. doi: 10.4103/aja.aja_59_20.
3
Conclusions about testosterone therapy and cardiovascular risk.关于睾酮治疗与心血管风险的结论。
Asian J Androl. 2018 Mar-Apr;20(2):152-153. doi: 10.4103/aja.aja_7_18.
4
Why is understanding the relationship of testosterone to cardiovascular risk so important?为什么了解睾酮与心血管风险之间的关系如此重要？
Asian J Androl. 2018 Mar-Apr;20(2):107-108. doi: 10.4103/aja.aja_71_17.
本文引用的文献
1
[Testosterone supplementary therapy for type-2 diabetes mellitus males with hypogonadism: Controversy and analysis].[睾酮补充疗法用于伴有性腺功能减退的2型糖尿病男性：争议与分析]
Zhonghua Nan Ke Xue. 2017 Aug;23(8):739-744.
2
[Testosterone Undecanoate Pills improves insulin resistance in type-2 diabetes men with hypogonadism].十一酸睾酮丸改善伴有性腺功能减退的2型糖尿病男性的胰岛素抵抗
Zhonghua Nan Ke Xue. 2017 Jun;23(6):517-521.
3
[Oral Testosterone Undecanoate Capsules combined with Qilin Pills for late-onset hypogonadism in males].十一酸睾酮口服胶囊联合麒麟丸治疗男性迟发性性腺功能减退症
Zhonghua Nan Ke Xue. 2017 May;23(5):455-458.
4
Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis.男性使用外源性睾酮的心血管风险：一项系统评价和荟萃分析。
Am J Med. 2017 Mar;130(3):293-305. doi: 10.1016/j.amjmed.2016.09.017. Epub 2016 Oct 14.
5
Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review.睾酮治疗、与年龄的关联、治疗起始及方式与心血管事件：一项系统评价
Clin Endocrinol (Oxf). 2016 Sep;85(3):436-43. doi: 10.1111/cen.13084. Epub 2016 May 11.
6
Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men.65岁以上患有迟发性性腺功能减退的老年男性与年轻男性从睾酮治疗中获益程度相同。
Korean J Urol. 2015 Apr;56(4):310-7. doi: 10.4111/kju.2015.56.4.310. Epub 2015 Mar 20.
7
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.男性性腺功能减退的诊断、治疗及监测建议
Aging Male. 2015 Mar;18(1):5-15. doi: 10.3109/13685538.2015.1004049. Epub 2015 Feb 6.
8
Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis.心血管风险和血清双氢睾酮升高因睾酮给药途径而异：一项系统评价和荟萃分析。
BMC Med. 2014 Nov 27;12:211. doi: 10.1186/s12916-014-0211-5.
9
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.与促睾酮药物相关的心血管风险：一项系统评价与荟萃分析
Expert Opin Drug Saf. 2014 Oct;13(10):1327-51. doi: 10.1517/14740338.2014.950653. Epub 2014 Aug 19.
10
Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.男性使用睾酮治疗处方后非致命性心肌梗死风险增加。
PLoS One. 2014 Jan 29;9(1):e85805. doi: 10.1371/journal.pone.0085805. eCollection 2014.
Zotero 插件